Business Description

Description
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset -0.21
Debt-to-Equity -2.38
Debt-to-EBITDA -0.39
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.89
Distress
Grey
Safe
Beneish M-Score -10.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 20.34
9-Day RSI 36.09
14-Day RSI 40.91
6-1 Month Momentum % -90
12-1 Month Momentum % -93.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.24
Quick Ratio 0.18
Cash Ratio 0.03
Days Inventory 69.53
Days Sales Outstanding 62.09
Days Payable 184.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -73.7
Shareholder Yield % -114.94

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 12.34
Operating Margin % -73.56
Net Margin % -277.18
FCF Margin % -44.68
ROE % -576.69
ROA % -175.15
ROIC % -46.61
ROC (Joel Greenblatt) % -252.53
ROCE % -280.43

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.11
EV-to-EBIT -0.47
EV-to-EBITDA -0.49
EV-to-Revenue 0.63
EV-to-FCF -1.89
Earnings Yield (Greenblatt) % -213.9
FCF Yield % -275.01

Financials

ASX:ME1DA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Melodiol Global Health Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 18.921
EPS (TTM) (A$) -0.362
Beta 1.88
Volatility % 102.67
14-Day RSI 40.91
14-Day ATR (A$) 0.000162
20-Day SMA (A$) 0.013
12-1 Month Momentum % -93.5
52-Week Range (A$) 0.012 - 0.44
Shares Outstanding (Mil) 538.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Melodiol Global Health Ltd Filings

Filing Date Document Date Form
No Filing Data

Melodiol Global Health Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Melodiol Global Health Ltd Frequently Asked Questions

What is Melodiol Global Health Ltd(ASX:ME1DA)'s stock price today?
The current price of ASX:ME1DA is A$0.01. The 52 week high of ASX:ME1DA is A$0.44 and 52 week low is A$0.01.
When is next earnings date of Melodiol Global Health Ltd(ASX:ME1DA)?
The next earnings date of Melodiol Global Health Ltd(ASX:ME1DA) is .
Does Melodiol Global Health Ltd(ASX:ME1DA) pay dividends? If so, how much?
Melodiol Global Health Ltd(ASX:ME1DA) does not pay dividend.

Press Release

Subject Date
No Press Release